Maintaining adequate fluid intake is essential to manage these side effects and support kidney health
3 Strong Oncology & Specialty Momentum: Beyond neuroscience, BMSs growth portfolio delivered $6.9B, led by: OPDIVO (nivolumab) US HCP: $2.5B (+8%) Breyanzi (lisocabtagene maraleucel) HCP: $359M (+58%) CAMZYOS (mavacamten) US HCP: $296M (+88%) These results reinforce BMSs transformation into a data-rich, diversified biopharma, with pivotal readouts expected in 2026 across fibrosis, multiple myeloma, and autoimmune indications
A placebo-controlled phase II clinical trial (NCT03987451) is evaluating the effect of semaglutide compared to placebo in patients with NAFLD and cirrhosis
RoohaniSClaenNMEhretFJaroschADziodzioTFlrckenAet alThe role of radiotherapy in the management of malignant peripheral nerve sheath tumors: a single-center retrospective cohort study
Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model
And you cannot verify purity or quality the same way you can with lyophilized powder